[go: up one dir, main page]

AU2016903799A0 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents

Compositions for the treatment of hypertension and/or fibrosis

Info

Publication number
AU2016903799A0
AU2016903799A0 AU2016903799A AU2016903799A AU2016903799A0 AU 2016903799 A0 AU2016903799 A0 AU 2016903799A0 AU 2016903799 A AU2016903799 A AU 2016903799A AU 2016903799 A AU2016903799 A AU 2016903799A AU 2016903799 A0 AU2016903799 A0 AU 2016903799A0
Authority
AU
Australia
Prior art keywords
fibrosis
hypertension
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016903799A
Inventor
Karen Annette Duggan
David Alan Winkler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Ltd
Original Assignee
Vectus Biosystems Ltd
Filing date
Publication date
Application filed by Vectus Biosystems Ltd filed Critical Vectus Biosystems Ltd
Publication of AU2016903799A0 publication Critical patent/AU2016903799A0/en
Priority to PCT/AU2017/051026 priority Critical patent/WO2018053587A1/en
Abandoned legal-status Critical Current

Links

AU2016903799A 2016-09-21 2016-09-21 Compositions for the treatment of hypertension and/or fibrosis Abandoned AU2016903799A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2017/051026 WO2018053587A1 (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis

Publications (1)

Publication Number Publication Date
AU2016903799A0 true AU2016903799A0 (en) 2016-10-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3634426A4 (en) Compositions for the treatment of fibrosis
EP3538189A4 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
EP3720421A4 (en) Compositions and methods for the treatment of metabolic conditions
EP3651747A4 (en) Compositions and methods for the treatment of eye disorders
TWI799397B (en) Compositions for the treatment of hypertension
EP3310783A4 (en) Methods and compositions for the prevention and treatment of hearing loss
EP3522873A4 (en) Compositions and methods for the treatment of xerostomia
PT3573620T (en) Compositions for the treatment of hypertension
EP3226873A4 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
EP3046901A4 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3046902A4 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3724293A4 (en) Asphalt compositions and methods of using the same
SG11202004005RA (en) Pharmaceutical compositions for controlling and/or reducing the progression of myopia
EP3426671A4 (en) Compounds and compositions for the treatment of infections
EP3256124A4 (en) Cenicriviroc for the treatment of fibrosis
EP3270985A4 (en) Polypeptide compositions and methods of using the same
EP3694517A4 (en) Compositions and methods for treatment of fibrosis
EP3500274A4 (en) Methods and compositions for the treatment of warts
EP3294294A4 (en) Compositions and methods for the treatment or prevention of pulmonary hypertension
EP3271320A4 (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
EP3554494A4 (en) Compositions and methods for the treatment of inflammation
EP3534924A4 (en) Composition for the prevention and/or treatment of cardiovascular diseases
IL265242B (en) Compositions for the treatment of hypertension and/or fibrosis
HK40116862A (en) Compositions for the treatment of hypertension